UnknownPhase 4Other

Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy

Sponsored by Hospices Civils de Lyon

NCT ID
NCT00129597
Target Enrollment
40 participants
Start Date
2004-12

About This Study

Prevalence of chronic pain after mastectomy is beyond 50% 3 months after surgery. This pain is related to a sensitization of the central nervous system through N-methyl-D-asparate (NMDA) receptors. Ketalar might prevent the occurrence of chronic pain by anti-NMDA properties after mastectomy.

Conditions Studied

PainBreast Cancer

Interventions

  • ketalar

Eligibility

Sex:FEMALE
Age:18 Years - 80 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Mastectomy in patients 18 to 80 years old

Exclusion Criteria:

* American Society of Anesthesiology (ASA) class \>= 3
* Renal, heart or hepatic failure
* Allergy to ketalar
* Psychiatric disease
* Chronic antalgic treatment

Study Locations (1)

Centre Hospitalier Lyon Sud
Pierre-Bénite, France

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy | Huxley